Debt-to-equity of Oruka Therapeutics, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Oruka Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Oruka Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 4%, a 40% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Oruka Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 4% -3% -40% 30 Sep 2025
Q2 2025 4% -9% -67% 30 Jun 2025
Q1 2025 4% -1% -15% 31 Mar 2025
Q4 2024 5% +2% +47% 31 Dec 2024
Q3 2024 7% +3% +75% 30 Sep 2024
Q2 2024 13% +8% +195% 30 Jun 2024
Q1 2024 5% 0% +4.5% 31 Mar 2024
Q4 2023 4% -2% -37% 31 Dec 2023
Q3 2023 4% -3% -43% 30 Sep 2023
Q2 2023 4% -3% -37% 30 Jun 2023
Q1 2023 5% -2% -28% 31 Mar 2023
Q4 2022 6% -1% -12% 31 Dec 2022
Q3 2022 7% 0% +2% 30 Sep 2022
Q2 2022 7% 30 Jun 2022
Q1 2022 7% 31 Mar 2022
Q4 2021 6% 31 Dec 2021
Q3 2021 6% 30 Sep 2021
Q4 2018 14% -3% -20% 31 Dec 2018
Q3 2018 16% +1% +6.7% 30 Sep 2018
Q2 2018 17% +5% +40% 30 Jun 2018
Q1 2018 18% +9% +94% 31 Mar 2018
Q4 2017 17% 31 Dec 2017
Q3 2017 15% 30 Sep 2017
Q2 2017 12% 30 Jun 2017
Q1 2017 9% 31 Mar 2017
Q4 2015 4% -2% -38% 31 Dec 2015
Q3 2015 5% -2% -27% 30 Sep 2015
Q2 2015 5% -1% -13% 30 Jun 2015
Q1 2015 7% +2% +32% 31 Mar 2015
Q4 2014 6% 0% -6.5% 31 Dec 2014
Q3 2014 6% 0% +7.1% 30 Sep 2014
Q2 2014 6% -1% -16% 30 Jun 2014
Q1 2014 5% -10% -64% 31 Mar 2014
Q4 2013 7% -6% -46% 31 Dec 2013
Q3 2013 6% -7% -55% 30 Sep 2013
Q2 2013 7% -6% -46% 30 Jun 2013
Q1 2013 15% +2% +16% 31 Mar 2013
Q4 2012 13% 31 Dec 2012
Q3 2012 13% 30 Sep 2012
Q2 2012 14% 30 Jun 2012
Q1 2012 13% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.